What TRH is
TRH is a hypothalamic releasing peptide that regulates TSH and prolactin-related pituitary signaling.
TRH is grouped under Endogenous / Biology / Approved / Clinical on PeptideFactCheck because it matters as one of the classic releasing hormones that shaped endocrine peptide medicine.
The useful starting point is to separate the molecule itself from the internet story around it. It matters as one of the classic releasing hormones that shaped endocrine peptide medicine.
Why people keep looking it up
It matters as one of the classic releasing hormones that shaped endocrine peptide medicine.
TRH is a hypothalamic releasing peptide that regulates TSH and prolactin-related pituitary signaling.
TRH tends to stay in the conversation because it touches a familiar public theme: hypothalamic peptide, thyroid axis, and pituitary signaling. That makes it easy for the claim to travel faster than the evidence.
What the evidence can support right now
Foundational endocrine peptide biology with diagnostic and historical drug relevance.
Human endocrine biology is well established.
Mechanistic support around thyroid-axis control is extensive.
Why this page carries the current tier: Foundational endocrine peptide biology with diagnostic and historical drug relevance.
The current seed trail for TRH is pulling from 2 databases sources and 1 literature source.
Safety, limits, and regulatory context
This is a reference endocrinology entry, not a broad self-optimization peptide category.
TRH is tracked here as endogenous biology.
Editorial boundary: PeptideFactCheck does not publish dosing, cycling, sourcing, injection, or administration instructions for TRH. The job here is to explain the public claim, the mechanism story, the evidence strength, and the current limits.
Molecular and identifier data
The current PubChem match for TRH is CID 638678. That gives the page a source-backed chemistry record rather than a placeholder identifier block.
- PubChem CID
- 638678
- Formula
- C16H22N6O4
- Molecular weight
- 362.38
- InChIKey
- XNSAINXGIQZQOO-SRVKXCTJSA-N
Matched synonyms include protirelin, 24305-27-9, Thyroliberin, Lopremone, Synthetic TRH, Rifathyroin, Thypinone, Thyrotropin-releasing factor.
Open PubChem recordClinical trial snapshot
The current ClinicalTrials.gov intervention query for TRH returns 21 study records. This does not prove efficacy by itself, but it does show whether the peptide is showing up in a formal trial registry rather than only in forums or vendor copy.
Literature snapshot
The current PubMed query for TRH returns 17953 results. The articles below are a quick literature surface so the page shows actual papers instead of only generic evidence labels.
Label and regulatory records
For approved or clinically developed peptides, the page now pulls in official labeling and FDA-facing records where they exist. That makes the regulatory section materially more useful than a generic approved or not-approved tag.
Source trail
Each linked source is shown directly so the page can be audited. The page now combines its editorial seed trail with automated official-source enrichment generated on 2026-04-24 from PubChem, ClinicalTrials.gov, PubMed, DailyMed, openFDA label, and Drugs@FDA.